Hot flash drug shows significant, rapid benefits in pivotal clinical trials
The investigational drug elinzanetant significantly reduces the frequency and severity of hot flashes associated with menopause while improving women’s quality of life, new UVA Health research published in the Journal of the American Medical Association shows. The nonhormonal drug, containing no estrogen, was tested in two phase 3 trials, Oasis 1 and 2, at dozens … Read more